CA-TIGO
23.1.2024 15:01:31 CET | Business Wire | Press release
Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy storage solutions, today announced the launch of the Tigo GO EV Charger for the German market. A smart charging station for electric vehicles, GO EV Charger offers seamless integration with the Tigo EI Residential solar-plus-storage solution. Available as both a single and three-phase charger up to 22 kW, the GO EV Charger can be wall-mounted indoors or outdoors and includes RFID technology for easy user authentication. With flexible charging modes tailored to accommodate homeowner use cases, the GO EV Charger can be installed and connected to the Tigo EI Inverter in minutes and managed centrally from the Tigo EI monitoring platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240123262185/en/
Available to the German market as a single and three-phase charger, the GO EV Charger offers flexible charging and easy management, tailored to accommodate each homeowner’s unique use case. (Photo: Business Wire)
“The synergy achieved by the integration of the charger with the solar-plus-storage solution marks a significant milestone in the journey towards a future of holistic residential energy systems,” said Klaus Besier, Managing Director at Germany’s Elektrobau Meffert GmbH, one of the first GO EV Charger customers. “As a PV installer, I believe it is crucial to have a comprehensive solution where the components are designed to work together seamlessly for an expeditious installation process. When you add the outstanding Tigo support team, which speaks the installer’s language, and the EI monitoring platform that empowers system owners to match solar energy production with their specific needs proactively, you have a winning combination. Tigo streamlines our ability to deliver more efficient and cohesive systems to more customers.”
With GO EV Charger, the Tigo EI Residential solution provides an efficient renewable energy ecosystem capable of generating, converting, storing, and managing solar energy from the roof down to the everyday needs of homeowners. On the web or through the Tigo EI App, Tigo provides homeowners with sophisticated management tools, and the Tigo Energy Intelligence platform serves as the central management platform for installers to monitor and manage the systems in their portfolios.
“Tigo’s journey first started with technological innovations to make solar safer and more efficient, followed by technologies that increase solar production and reduce operating costs as well as power conversion and energy storage, and the GO EV Charger is a natural next step in this evolution,” said Massimo Migliorini, Director Business Development EMEA – EI at Tigo Energy. “Homeowners have the capacity not only to generate clean and sustainable energy but to intelligently manage, store, and use it in once unimaginable ways. This milestone exemplifies Tigo’s unwavering commitment to renewable energy and giving individuals the power to actively contribute to a cleaner, greener future.”
The release of the GO EV Charger comes on the heels of an introductory webinar scheduled for February 5th. This will be followed by digital and live training events for German PV professionals, hosted with Tigo distribution partners in Germany between February and March. Additionally, the training offered by Tigo Academy – also available in German – will be enhanced by a series of technical content dedicated to the new Tigo solution for e-mobility.
For GO EV Charger ordering information and to get connected with an experienced member of the Tigo team, visit tigoenergy.com/contacts.
About Tigo Energy
Founded in 2007, Tigo is a worldwide leader in the development and manufacture of smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Tigo combines its Flex MLPE (Module Level Power Electronics) and solar optimizer technology with intelligent, cloud-based software capabilities for advanced energy monitoring and control. Tigo MLPE products maximize performance, enable real-time energy monitoring, and provide code-required rapid shutdown at the module level. The company also develops and manufactures products such as inverters and battery storage systems for the residential solar-plus-storage market. For more information, please visit www.tigoenergy.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240123262185/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom